The European Commission welcomes the swift adoption by the Council of the proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta – markets that have been historically supplied through or by Great Britain. This adoption follows last week’s […]
Spain sends a new shipment of 8 tons of health material and medicines for the Ukrainian population
The Government of Spain has sent this morning a new shipment of 8 tons of medical supplies to meet the needs of the Ukrainian population that has been forced to leave their country and is currently a refugee in Poland. The Minister of Health, Carolina Darias, has gone this morning to the storage center of […]
Traineeship in the European Medicines Agency
The European Medicines Agency organises traineeships for university graduates in its headquarters in Amsterdam, The Netherlands. The programme aims to give trainees an understanding of the Agency and its role within the activities of the European Union. It also enables them to acquire practical knowledge in one of the EMA’s Units and to obtain professional […]
Affordable, accessible and safe medicines for all: the Commission presents a Pharmaceutical Strategy for Europe
The Commission has adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry. Europe’s Pharmaceutical Strategy has four main objectives: Ensuring access to affordable medicines for patients, and addressing unmet medical needs (e.g. in the […]
Regulatory flexibility to ensure availability of veterinary medicines during COVID-19
The European Commission, EMA and the Coordination Group for Mutual Recognition and Decentralised Procedure – Veterinary (CMDv) have issued guidance on adaptations to the regulatory framework to companies that develop, manufacture and distribute veterinary medicines in order to address some of the constraints posed by the COVID-19 pandemic. According to the jointly developed question-and-answer (Q&A) document, regulatory rules […]